IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to .

Front Immunol

Institut National de la Santé et de la Recherche Médicale Unité 1138, Paris, France; UMR S 1138, Sorbonne Universités, UPMC Univ Paris, Paris, France; Centre de Recherche des Cordeliers, Equipe - Immunopathology and Therapeutic Immunointervention, Paris, France; UMR S 1138, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Published: November 2016

The programed death-1 (PD-1)-programed death ligand-1 (PD-L1) and PD-L2 co-inhibitory pathway has been implicated in the evasion strategies of . Specifically, -induced PD-L1 orchestrates expansion of regulatory T cells and suppression of Th1 response. However, the role of PD pathway in regulating Th17 response to has not been investigated. In the present report, we demonstrate that and -derived antigen fractions have differential abilities to mediate human monocyte- and dendritic cell (DC)-mediated Th17 response and were independent of expression of PD-L1 or PD-L2 on aforementioned antigen-presenting cells. Importantly, we observed that blockade of PD-L1 or PD-1 did not significantly modify either the frequencies of Th17 cells or the production of IL-17 from CD4 T cells though IFN-γ response was significantly enhanced. On the contrary, IL-1β from monocytes and DCs were critical for the Th17 response to . Together, our results indicate that IL-1β, but not members of the programed death pathway, is critical for human Th17 response to .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095489PMC
http://dx.doi.org/10.3389/fimmu.2016.00465DOI Listing

Publication Analysis

Top Keywords

th17 response
20
programed death-1
8
programed death
8
pathway critical
8
critical human
8
human th17
8
pd-l1 pd-l2
8
response
7
th17
6
il-1β programed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!